259 related articles for article (PubMed ID: 27868156)
1. Vaginal and sexual health treatment strategies within a female sexual medicine program for cancer patients and survivors.
Carter J; Stabile C; Seidel B; Baser RE; Goldfarb S; Goldfrank DJ
J Cancer Surviv; 2017 Apr; 11(2):274-283. PubMed ID: 27868156
[TBL] [Abstract][Full Text] [Related]
2. Validation of Clinical Tools for Vaginal and Vulvar Symptom Assessment in Cancer Patients and Survivors.
Eaton AA; Baser RE; Seidel B; Stabile C; Canty JP; Goldfrank DJ; Carter J
J Sex Med; 2017 Jan; 14(1):144-151. PubMed ID: 28011209
[TBL] [Abstract][Full Text] [Related]
3. Baseline characteristics and concerns of female cancer patients/survivors seeking treatment at a Female Sexual Medicine Program.
Carter J; Stabile C; Seidel B; Baser RE; Gunn AR; Chi S; Steed RF; Goldfarb S; Goldfrank DJ
Support Care Cancer; 2015 Aug; 23(8):2255-65. PubMed ID: 25567673
[TBL] [Abstract][Full Text] [Related]
4. The acceptability, feasibility, and efficacy (phase I/II study) of the OVERcome (Olive Oil, Vaginal Exercise, and MoisturizeR) intervention to improve dyspareunia and alleviate sexual problems in women with breast cancer.
Juraskova I; Jarvis S; Mok K; Peate M; Meiser B; Cheah BC; Mireskandari S; Friedlander M
J Sex Med; 2013 Oct; 10(10):2549-58. PubMed ID: 23635341
[TBL] [Abstract][Full Text] [Related]
5. Simple strategies for vaginal health promotion in cancer survivors.
Carter J; Goldfrank D; Schover LR
J Sex Med; 2011 Feb; 8(2):549-59. PubMed ID: 20722792
[TBL] [Abstract][Full Text] [Related]
6. A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors.
Carter J; Baser RE; Goldfrank DJ; Seidel B; Milli L; Stabile C; Canty J; Saban S; Goldfarb S; Dickler MN; Gardner GJ; Jewell EL; Sonoda Y; Kollmeier MA; Alektiar KM
Support Care Cancer; 2021 Jan; 29(1):311-322. PubMed ID: 32358778
[TBL] [Abstract][Full Text] [Related]
7. A single-arm clinical trial investigating the effectiveness of a non-hormonal, hyaluronic acid-based vaginal moisturizer in endometrial cancer survivors.
Carter J; Goldfarb S; Baser RE; Goldfrank DJ; Seidel B; Milli L; Saban S; Stabile C; Canty J; Gardner GJ; Jewell EL; Sonoda Y; Kollmeier MA; Alektiar KM
Gynecol Oncol; 2020 Aug; 158(2):366-374. PubMed ID: 32522420
[TBL] [Abstract][Full Text] [Related]
8. Sexual health needs and educational intervention preferences for women with cancer.
Stabile C; Goldfarb S; Baser RE; Goldfrank DJ; Abu-Rustum NR; Barakat RR; Dickler MN; Carter J
Breast Cancer Res Treat; 2017 Aug; 165(1):77-84. PubMed ID: 28547655
[TBL] [Abstract][Full Text] [Related]
9. [Quality of life and sexual function of cervical cancer patients following radical hysterectomy and vaginal extension].
Ye S; Yang J; Cao D; Zhu L; Lang J; Shen K
Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):609-15. PubMed ID: 25354863
[TBL] [Abstract][Full Text] [Related]
10. Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel.
Caruso S; Cianci S; Amore FF; Ventura B; Bambili E; Spadola S; Cianci A
Menopause; 2016 Jan; 23(1):47-54. PubMed ID: 26079974
[TBL] [Abstract][Full Text] [Related]
11. Vaginal Dilators: Issues and Answers.
Liu M; Juravic M; Mazza G; Krychman ML
Sex Med Rev; 2021 Apr; 9(2):212-220. PubMed ID: 32014450
[TBL] [Abstract][Full Text] [Related]
12. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
Vicariotto F; DE Seta F; Faoro V; Raichi M
Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
[TBL] [Abstract][Full Text] [Related]
13. Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview.
Sinha A; Ewies AA
Climacteric; 2013 Jun; 16(3):305-12. PubMed ID: 23215675
[TBL] [Abstract][Full Text] [Related]
14. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
Vicariotto F; Raichi M
Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
[TBL] [Abstract][Full Text] [Related]
15. Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial.
Ganz PA; Greendale GA; Petersen L; Zibecchi L; Kahn B; Belin TR
J Natl Cancer Inst; 2000 Jul; 92(13):1054-64. PubMed ID: 10880548
[TBL] [Abstract][Full Text] [Related]
16. Qualitative accounts of patients' determinants of vaginal dilator use after pelvic radiotherapy.
Bakker RM; Vermeer WM; Creutzberg CL; Mens JW; Nout RA; Ter Kuile MM
J Sex Med; 2015 Mar; 12(3):764-73. PubMed ID: 25424559
[TBL] [Abstract][Full Text] [Related]
17. Quality of life and menopausal and sexual symptoms in gynecologic cancer survivors: a cohort study.
Vaz AF; Pinto-Neto AM; Conde DM; Costa-Paiva L; Morais SS; Pedro AO; Esteves SB
Menopause; 2011 Jun; 18(6):662-9. PubMed ID: 21471827
[TBL] [Abstract][Full Text] [Related]
18. Sexual inactivity in partnered female cancer survivors.
Marino JL; Saunders CM; Hickey M
Maturitas; 2017 Nov; 105():89-94. PubMed ID: 28528727
[TBL] [Abstract][Full Text] [Related]
19. A Prospective Single-Arm Study Evaluating the Effects of a Multimodal Physical Therapy Intervention on Psychosexual Outcomes in Women With Dyspareunia After Gynecologic Cancer.
Cyr MP; Dumoulin C; Bessette P; Pina A; Gotlieb WH; Lapointe-Milot K; Mayrand MH; Morin M
J Sex Med; 2021 May; 18(5):946-954. PubMed ID: 33931347
[TBL] [Abstract][Full Text] [Related]
20. Sexual activity and vaginal topography in women with symptomatic pelvic floor disorders.
Edenfield AL; Levin PJ; Dieter AA; Amundsen CL; Siddiqui NY
J Sex Med; 2015 Feb; 12(2):416-23. PubMed ID: 25293781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
